Advertisement

Hereditary colon cancer syndromes: polyposis and nonpolyposis (Lynch syndromes I & II) variants

  • Henry T. Lynch
  • Stephen J. Lanspa
  • Jane F. Lynch
Part of the Cancer Treatment and Research book series (CTAR, volume 33)

Abstract

Colorectal cancer is second in incidence only to lung cancer in many of the western industrialized nations [1]. Its incidence has shown a steady increase since the turn of the century, a trend which has been attributed by some to changes in dietary patterns [2]. While environmental factors are of unquestionable significance in the etiology of colorectal cancer, the role of genetic factors, as in all forms of human diseases, must be considered. Unfortunately, in the case of colorectal cancer, with the exception of familial multiple adenomatous polyposis coli (FPC), the importance of genetics has been severely neglected. Recently, this entire subject has been extensively reviewed [3–5].

Keywords

Colorectal Cancer Lynch Syndrome Adenomatous Polyp Colonic Polyp Hereditary Nonpolyposis Colorectal Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Silverberg E. 1984. Cancer statistics 1984 (American Cancer Society). Ca 34:7–23.PubMedGoogle Scholar
  2. 2.
    Byers T, Graham S. 1984. The epidemiology of diet and cancer. Adv. Cancer Res 41: 1–69.PubMedGoogle Scholar
  3. 3.
    Lynch PM, Lynch HT. 1985. Colon Cancer Genetics. Van Nostrand Reinhold Co., New York.Google Scholar
  4. 4.
    Lynch HT, Rozen P, Schuelke GS. 1985. Hereditary colon cancer: polyposis and nonpolyposis variants. Ca 35:95–115.PubMedGoogle Scholar
  5. 5.
    Lynch HT, Rozen P, Schuelke GS, Lynch JF. 1984. Hereditary colorectal cancer review: colonic polyposis and nonpolyposis colonic cancer (Lynch syndrome I and II). Surv Dig Dis 2:244–260.Google Scholar
  6. 6.
    Moore JRL, Lamont JT. 1984. Colorectal cancer: risk factors and screening strategies. Arch Int Med 144:1819–1823.Google Scholar
  7. 7.
    Lynch HT. 1981. Genetics and Breast Cancer. Van Nostrand Reinhold Co., New York.Google Scholar
  8. 8.
    Broca PP. 1969. Traite des Tumeurs, 1866–1969, Vols. 1 & 2. P. Asselin, Paris.Google Scholar
  9. 9.
    Warthin AS. 1913. Heredity with reference to carcinoma. Arch Int Med 12:546–555.Google Scholar
  10. 10.
    Lynch HT, Krush AJ. 1971. Cancer family ‘G’ revisited: 1895–1970. Cancer 27: 1505–1511.PubMedGoogle Scholar
  11. 11.
    Lynch HT, Lynch PM, Albano WA, Lynch JF. 1981. The Cancer Family Syndrome: a status report. Dis Colon Rect 24:311–322.Google Scholar
  12. 12.
    Warthin AS. 1931. Heredity of carcinoma in man. Ann Int Med 4:681–696.Google Scholar
  13. 13.
    Simpson WM. 1931. Bookshelf browsing: Aldred Scott Warthin, 1866–1931. Am J Surg 14:502–504.Google Scholar
  14. 14.
    Lynch HT, Lynch JF. 1985. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II): a common genotype linked to oncogenes? Med. Hypoth 18:19–28.Google Scholar
  15. 15.
    Bulow S. 1984. Review: colorectal polyposis syndromes. Scand J Gastroenterol 19:289.PubMedGoogle Scholar
  16. 16.
    Lynch HT. 1976. Cancer Genetics. Charles C. Thomas Co, Springfield.Google Scholar
  17. 17.
    Bulow S, Sondergaard JO, Witt I, Larsen E, Tetens, G. 1984. Mandibular osteomas in familial polyposis coli. Dis Colon Rect 27:105–108.Google Scholar
  18. 18.
    Utsunomiya J, Nakamura T. 1975. The occult osteomatous changes in the mandible in patients with familial polyposis coli. Br J Surg 62:45–51.PubMedGoogle Scholar
  19. 19.
    Lynch HT, Ruma TA, Albano WA, Lynch JF, Lynch PM. 1982. Phenotypic variation in hereditary adenomatosis: Unusual tumor spectrum. Dis Colon Rect 25:235–238.Google Scholar
  20. 20.
    Hisatomi K, Ohsato K, Sugita A, Takaki A, Kuroda Y, Shirai Z, Kolde O. 1985. Embryonal carcinoma of the testis associated with familial adenomatosis coli: report of a case. Dis Colon Rect 28:168–170.Google Scholar
  21. 21.
    Butson ARC. 1983. Familial multiple polyposis coli with multiple associated tumors. Dis Colon Rect 26:578–582.Google Scholar
  22. 22.
    Painter TA, Jagelman DG. 1985. Adrenal adenomas and adrenal carcinomas in association with hereditary adenomatosis of the colon and rectum. Cancer 55:2001–2004.PubMedGoogle Scholar
  23. 23.
    Jarvinen HJ, Nyberg M, Peltokallio P. 1983. Biliary involvement in familial adenomatosis coli. Dis Colon Rect 26:525–528.Google Scholar
  24. 24.
    Weinberger JM, Cohen Z, Berk T. 1981. Polyposis coli preceded by hepatocellular carcinoma: report of a case. Dis Colon Rect 24:296–300.Google Scholar
  25. 25.
    Zeze F, Ohsato K, Mitani H, Ohkuma R, Koide O. 1983. Hepatocellular carcinoma associated with familial polyposis of the colon: report of a case. Dis Colon Rect 26: 465–468.Google Scholar
  26. 26.
    Veale AM. 1965. Intestinal polyposis: eugenics laboratory memoir, series 40. Cambridge Univ Press, New York, pp 27–29.Google Scholar
  27. 27.
    Kingston JE, Herbert A, Moper GJ, Mann JR 1983. Association between hepatoblastoma and polyposis coli. Arch Dis Child 58:959–962.PubMedGoogle Scholar
  28. 28.
    Coffey RJ, Knight CD, Van Heerden JA, Weiland LH. 1985. Gastric adenocarcinoma complicating Gardner’s syndrome in a North American woman. GE 88:1263–1266.Google Scholar
  29. 29.
    Thompson JS, Harned RK, Anderson JC, Hodgson PE. 1983. Papillary carcinoma of the thyroid and familial polyposis coli. Dis Colon Rect 26:583–585.Google Scholar
  30. 30.
    Burt RW, Berenson MM, Lee RG, Tolman KG, Freston JW, Gardner EJ. 1904. Upper gastrointestinal polyps in Gardner’s syndrome. G.E. 86:295–301.Google Scholar
  31. 31.
    Jarvinen H, Nyberg M, Peltokalio P. 1983. Upper gastrointestinal tract polyps in familial adenomatosis coli. Gut 24:333–339.PubMedGoogle Scholar
  32. 32.
    Ushio K, Sasagawa M, Doi H, Yamada T, Ichikawa H, Hojo K, Koyama Y, Sand R. 1976. Lesions associated with familial polyposis coli: studies of lesions of the stomach, duodenum, bones, and teeth. Gastrointest. Rad 1:67–80.Google Scholar
  33. 33.
    Phillips LG. 1981. Polyposis and carcinoma of the small bowel and familial colonic polyposis. Dis Colon Rect 24:478–481.Google Scholar
  34. 34.
    Hamilton SR, Bussey HJR, Mendelsohn G, Diamond MP, Pavlides G, Hutcheon D, Harbison M, Shermeta D, Morson BC, Yardley JH. 1979. Ileal adenomas after colectomy in nine patients with adenomatous polyposis coli/Gardner’s syndrome. GE 77:1252–1257.Google Scholar
  35. 35.
    Sachatello CR, Pickrin JW, Grace JT. 1970 Generalized juvenile gastrointestinal polyposis: a hereditary syndrome. GE 58:699–708.Google Scholar
  36. 36.
    Jarvinen H, Franssila KO. 1984. Familial juvenile polyposis coli: increased risk of colorectal cancer. Gut 25:792–800.PubMedGoogle Scholar
  37. 37.
    Ramaswamy G, Elhosseiny AA, Tchertkoff V. 1984. Juvenile polyposis of the colon with atypical adenomatous changes and carcinoma in situ: report of a case and review of the literature. Dis Colon Rect 27:393–398.Google Scholar
  38. 38.
    Boland CR, Troncale FJ. 1984. Familial colonic cancer in the absence of antecedent polyposis. Ann Int Med 100:700–701.PubMedGoogle Scholar
  39. 39.
    Albano WA, Recabaren JA, Lynch HT, Campbell AS, Mailliard JA, Organ CH, Kimberling WJ. 1982. Natural history of hereditary cancer of the breast and colon. Cancer 50: 360–363.PubMedGoogle Scholar
  40. 40.
    Lynch HT, Voorhees GJ, Lanspa SJ, McGreevy PS, Lynch JF. 1985. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer 52:271–273.PubMedGoogle Scholar
  41. 41.
    Sorensen SA, Jensen OA, Klinken L. 1983. Familial aggregation of neuroectodermal and gastrointestinal tumors. Cancer 52:1977.PubMedGoogle Scholar
  42. 42.
    Lynch HT, Lynch PM, Pester J, Fusaro RM. 1980. The Cancer Family Syndrome: rare cutaneous phenotypic linkage of Torre’s syndrome. Arch Int Med 141:607–611.Google Scholar
  43. 43.
    Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. 1985. Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome. Br J Derm 113:295–301.Google Scholar
  44. 44.
    Love RR. 1985. Small bowel cancers, B-cell lymphatic leukemia, and six primary cancers with metastases and prolonged survival in the Cancer Family Syndrome of Lynch. Cancer 55:499–502.PubMedGoogle Scholar
  45. 45.
    Budd DC, Fink DL. 1981. Mucoid colonic carcinoma as an autosomal-dominant inherited syndrome. Arch Surg 116:901–905.PubMedGoogle Scholar
  46. 46.
    Lynch HT, Drouhard TJ, Schuelke GS, Biscone KA, Lynch JF, Danes BS. 1985. Hereditary nonpolyposis colorectal cancer in a Navajo Indian family. Ca Genet Cytogenet 15:209–213.Google Scholar
  47. 47.
    Mir-Madjlessi SSH, Vafal M, Khademi J, Kamalian N. 1984. Coexisting primary malignant lymphoma and adenocarcinoma of the large intestine in an IgA-deficient boy. Dis Colon Rect 27:822–824.Google Scholar
  48. 48.
    Hamoudi AB, Ertel I, Newton WA, Reiner CB, Clatworthy HW. 1974. Multiple neoplasms in an adolescent child associated with IgA deficiency. Cancer 33:1134–1144.PubMedGoogle Scholar
  49. 49.
    Pines A, Rozen P, Ron E, Gilat T. 1985. Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 80:266–269.PubMedGoogle Scholar
  50. 50.
    Stuarte EA, Petrini J, Hershman JM. 1984. Acromegaly and colon cancer. Ann Int Med 101:627–628.Google Scholar
  51. 51.
    Klein I. 1984. Acromegaly and cancer. Ann Int Med 101:706–707.PubMedGoogle Scholar
  52. 52.
    Winkler H, Kott I, Reiss R. 1983. Site-specific, simultaneous presentation of colonic carcinoma in identical twins. Dis Colon Rect 26:344–346.Google Scholar
  53. 53.
    Lynch HT, Kimberling WJ, Biscone KA, Lynch JF, Wagner CA, Brennan K, Mailliard J A, Johnson PS. 1985. Familial heterogeneity of colon cancer risk. Cancer (submitted for publication).Google Scholar
  54. 54.
    Lynch HT, Fitzgibbons R Jr, Marcus J, McGill J, Voorhees GJ, Lynch JF. 1985 Colorectal cancer in a nuclear family: familial or hereditary? Dis Colon Rect 28:310–316.Google Scholar
  55. 55.
    Bulow S. 1984. Personal communication.Google Scholar
  56. 56.
    Boyne PJ. 1960. Incidence of osteosclerotic areas in the mandible and maxilla. J Oral Surg 18:486–491.Google Scholar
  57. 57.
    Danes BS. 1978. Increased in vitro tetraploidy: tissue specificity within heritable colorectal cancer syndromes with polyposis coli. Cancer 41:2330–2334.PubMedGoogle Scholar
  58. 58.
    Lipkin M, Blattner WE, Fraumeni JF, Lynch HT, Deschner E, Winawer S. 1983. Tritiated thymidine (ø p, ø h) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res. 43:1899–1904.PubMedGoogle Scholar
  59. 59.
    Lipkin M, Blattner WA, Gardner EJ, Burt RW, Lynch H, Deschner E, Winawer S, Fraumeni JF. 1984. Classification and risk assessment of individuals with familial polyposis, Gardner’s syndrome, and familial non-polyposis colon cancer from (3H) thymidine labeling patterns in colonic epithelial cells. Cancer Res 44:4201–4207.PubMedGoogle Scholar
  60. 60.
    Lynch HT, Kimberling W, Albano W, Lynch JF, Biscone K, Schuelke GS, Danes BS, Lipkin M, Deschner E, Mikol Y, Sandberg AA. 1985. Hereditary nonpolyposis colorectal cancer: Part I-clinical description of resource. Cancer 156:934–938.Google Scholar
  61. 61.
    Lynch HT, Schuelke GS, Kimberling W, Albano W, Lynch JF, Biscone K, Danes BS, Lipkin M, Deschner E, Mikol Y, Sandberg AA. 1985. Hereditary nonpolypoposis colonectal cancer: Part II-biomarker studies. Cancer 56:939–951.PubMedGoogle Scholar
  62. 62.
    Bacon HE. 1958. Ulcerative Colitis. J.B. Lippincott, Philadelphia.Google Scholar
  63. 63.
    Binder V, Weeke E, Olsen JH, Anthonisen P, Riis P. 1966. A genetic study of ulcerative colitis. Scand J Gastroenterol. 1:49–56.PubMedGoogle Scholar
  64. 64.
    Harned RK. 1982. Radiological aspects of the gastrointestinal cancer-associated genodermatoses. In: Cancer-Associated Genodermatoses (HT Lynch, RM Fusaro, eds.). Van Nostrand Reinhold Co, New York, pp 223–299.Google Scholar
  65. 65.
    Hersh AH, Stecher RM, Solomon WM, Wolpaw R, Hauser H. 1950. Heredity in ankylosing spondylitis. Am J Hum Genet 2:391–408.PubMedGoogle Scholar
  66. 66.
    Kirsner JB, Spencer JA. 1963. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Int Med 59:133–144.PubMedGoogle Scholar
  67. 67.
    Lagercrantz R, Perlmann P, Hammarstrom S. 1971. Immunological studies in ulcerative colitis. V. Family studies. Gastroenterology 60:381–389.PubMedGoogle Scholar
  68. 68.
    Lewkonia RM, McConnell RB. 1976. Familial inflammatory bowel diseaseheredity or environment? Gut 17:235–241.PubMedGoogle Scholar
  69. 69.
    Mayberry JF, Dew MJ, Morris JS. 1982. Monozygotic twins with ulcerative colitis. Postgrad Med J 58:112–114.PubMedGoogle Scholar
  70. 70.
    Moltke O. 1950. Familial occurrence of nonspecific suppurative coloproctitis. Acta Med Scand (Suppl) 77:426–524.Google Scholar
  71. 71.
    Morris PJ. 1965. Familial ulcerative colitis. Gut 6:176–178.PubMedGoogle Scholar
  72. 72.
    Paulley JW. 1950. Ulcerative colitis: a study of 173 cases. Gastoenterology 16:566–576.Google Scholar
  73. 73.
    Sachar DB. 1983. New concepts of cancer. Mt Sinai J Med 50:133–137.PubMedGoogle Scholar
  74. 74.
    Sanford GE. 1971. Genetic implications in ulcerative colitis. Am Surg 37:512–517.PubMedGoogle Scholar
  75. 75.
    Webb LR. 1950. The occurrence of chronic ulcerative colitis in twin males. Gastroenterology 15:523–524.PubMedGoogle Scholar
  76. 76.
    Korelitz BI. 1983. IBD in families, pregnancy, and childhood. Mt Sinai J Med 50: 181–186.PubMedGoogle Scholar
  77. 77.
    DuFrain RJ. 1985. Is cancer of the colon familial in cotton-top Tamarins? Ca Genet Cytogenet 14:83–87.Google Scholar
  78. 78.
    Shorter RG. 1984. Intestinal cancer in Crohn’s disease. Bull NY Acad Med 60:980–986.Google Scholar
  79. 79.
    Barnabei VM, Kelly TE. 1982. Bloom’s syndrome fibroblasts secrete a metabolite which enhances SCE rate in normal fibroblasts. Am J Med Genet 12:245.PubMedGoogle Scholar
  80. 80.
    Filipe MI, Mughal S, Bussey HJ. 1980. Patterns of mucus secretion in the colonic epithelium in familal polyposis. Invest Cell Pathol 4:329–343.Google Scholar
  81. 81.
    Friedman E, Carnright K, Lipkin M. 1982. Differential response of familial polyposis fibroblasts to two bifunctional alkylating agents. Carcinogenesis 3:1481–1485.PubMedGoogle Scholar
  82. 82.
    Fudenberg HH, Schuman SH, Goust JM, Jorgenson R. 1978. T-cells, precocious aging, and familial neoplasia. Gerontology 24:266–275.PubMedGoogle Scholar
  83. 83.
    Giannelli F, Botcherby PK, Avery JA. 1982. The effect of aphidicolin on the rate of DNA replication and unscheduled DNA synthesis of Bloom’s syndrome and normal fibroblasts. Hum. Genet 60:357–359.PubMedGoogle Scholar
  84. 84.
    Katano M, Fujiwara H, Toyoda K, Torisu M. 1980. Immunogenetic studies of familial large bowel cahcer. Gann 71:583–588.PubMedGoogle Scholar
  85. 85.
    Kinsella TJ, Little JB, Nove J, Weichselbaum RR, Li FP, Meyer RJ, Marchetto DJ, Patterson WB. 1982. Heterogeneous response to X-ray and ultraviolet light irradiations of cultured skin fibroblasts in two families with Gardner’s syndrome. JNCI 68:697–701.PubMedGoogle Scholar
  86. 86.
    Kopelovich L, Conlon S, Pollack R. 1977. Defective organization of actin in cultured skin fibroblasts from patients with inherited adenocarcinoma. Proc Natl Acad Sci USA 74:3019–3022.PubMedGoogle Scholar
  87. 87.
    Kopelovich L. 1982 Genetic predisposition to cancer in man: in vitro studies. Int Rev Cytol 77:63–88.PubMedGoogle Scholar
  88. 88.
    Kopelovich L, Gardner E. 1983. The use of a tumor promoter for the detection of individuals with the Gardner syndrome. Cancer 51:716–720.PubMedGoogle Scholar
  89. 89.
    Kuhn EM. 1981. High incidence of mitotic chiasmata in endoreduplicated Bloom’s syndrome cells. Hum Genet 58:417–421.PubMedGoogle Scholar
  90. 90.
    Macrae FA, Roberts-Thomson IC, Russell MD, St. John DJB. 1981. Familial colorectal cancer and hereditary brachydactyly. Br Med J 282:143–1432.Google Scholar
  91. 91.
    Miyaki M, Akamatsu N, Rokutanda M, Ono T, Yoshikura H, Sasaki M, Tonomura A, Utsunomiya J. 1980. Increased sensitivity of fibroblasts of skin from patients with adenomatosis coli and Peutz-Jegher’s syndrome to transformation by murine sarcoma virus. Gann 71:797–803.PubMedGoogle Scholar
  92. 92.
    Miyaki M, Akamatsu N, Ono T, Tonomura A, Utsunomiya J. 1982. Morphologic transformation and chromosomal changes induced by chemical carcinogens in skin fibroblasts from patients with familial adenomatosis coli. JNCI 68:563–571.PubMedGoogle Scholar
  93. 93.
    Pero RW, Miller DG, Lipkin M, Markowitz M, Gupta S, Winawer SJ, Enker W, Good RA. 1983. Reduced capacity for DNA repair synthesis in patients with or genetically predisposed to colorectal cancer. JNCI 70:867–875.PubMedGoogle Scholar
  94. 94.
    Taniguchi N, Mukai M, Nagaoki T, Miyawaki T, Moriya N, Takahashi H, Kondo N. 1982. Impaired B-cell differentiation and T-cell regulatory function in four patients with Bloom’s syndrome. Clin Immunol Immunopathol 22:247–258.PubMedGoogle Scholar
  95. 95.
    West J, Lyttleton MJ, Giannelli F. 1981. Effect of incubation temperature on the frequency of sister chromatid exchanges in Bloom’s syndrome lymphocytes. Hum Genet 59: 204–207.PubMedGoogle Scholar
  96. 96.
    Yonezawa S, Nakamura T, Tanaka S, Maruta K, Nishi M, Sato E: 1983. Binding of Ulex europaeus agglutinin-1 in polyposis coli: comparative study with solitary adenoma in the sigmoid colon and rectum. JNCI 71:19–24.PubMedGoogle Scholar
  97. 97.
    Bailey-Wilson JE, Elston RC, Schuelke GS, Kimberling W, Albano W, Lynch JF, Lynch HT. 1986. Segregation analysis of hereditary nonpolyposis colorectal cancer. Genet Epi 3:27–38.Google Scholar
  98. 98.
    Lynch HT, Krush AJ. 1968. Delay: a deterrent to cancer detection. Arch Environ Health 17:204–209.PubMedGoogle Scholar
  99. 99.
    Lynch HT, Krush AJ. 1968. Attitudes and delay in cancer detection. Cancer 18: 287–293.Google Scholar
  100. 100.
    Lynch HT, Krush AJ. 1969. Breast carcinoma and delay in treatment. Surg Gyn Obstet 128:1027–1032.Google Scholar
  101. 101.
    Lynch HT, Krush AJ. 1969. Delay factors in detection of cancer of the penis. NE Med J 54:360–367.Google Scholar
  102. 102.
    Lynch HT, Krush AJ. 1970. Delay: a problem in cancer control. NE Med J 55: 655–662.Google Scholar
  103. 103.
    Lynch HT, Krush AJ, Lipp M. 1972. The delay problem in cancer. Med Times 100: 76–87.PubMedGoogle Scholar
  104. 104.
    Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA. 1985. Fecal blood levels in health and disease: a study using hemoquant. NEJM 312:1422–1428.PubMedGoogle Scholar
  105. 105.
    Lipkin M, Winawer SJ, Sherlock P. 1981. Early identification of individuals at increased risk for cancer of the large intestine, Part I: definition of high risk populations. Meml SK Can Ctr Clin Bull 11:13–21.Google Scholar
  106. 106.
    Shimkin MB. 1975. Preventive oncology. Prev Med 4:106–114.PubMedGoogle Scholar
  107. 107.
    Farber EE, Camera RG, Laishes B, Lin J-C, Medline A, Ogawa K, Solt BB. 1979. Cellular and molecular markers of the carcinogenic process. In: Carcinogens: Identification and Mechanism of Action (AC Griffin, CR Shaw, eds.). Raven Press, New York, pp 313–335.Google Scholar
  108. 108.
    Pitot HC, Barrness L, Kitagawa T. 1978. Stages in the process of heptocarcinogenesis in rat liver. In: Carcinogenesis: A Comprehensive Survey, Vol. 2 (TJ Slaga, A Sivak, RK Boutwell, eds.). Raven Press, New York, pp 433–442Google Scholar
  109. 109.
    Sugarbaker PH, MacDonald JS, Gunderson LL. 1982. Colorectal cancer. In: Cancer: Principles and Practice of Oncology (VT De Vita, S Hellman, SA Rosenberg, eds.). Lippincott, Philadelphia, pp 643–723.Google Scholar
  110. 110.
    Spratt JS, Ackerman LV, Moyer CA. 1958. Relationship of polyps of the colon to colonic cancer. Ann Surg 148:682–698.PubMedGoogle Scholar
  111. 111.
    Kjeldsberg CR, Altshuler JH. 1970. Carcinoma in situ of the colon. Dis Colon Rect 13:376–381.Google Scholar
  112. 112.
    Morson BC, Pang LSC. 1967. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 8:423–434.PubMedGoogle Scholar
  113. 113.
    Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. 1983. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet ii: 149–152.Google Scholar
  114. 114.
    Riddell RH, Goldman H, Ransohoff DF, Appleman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardley JH. 1983. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14:931–968.PubMedGoogle Scholar
  115. 115.
    Correa P, Haenszel W. 1978. The epidemiology of large bowel cancer. Adv Can Res 26: 1–141.Google Scholar
  116. 116.
    Lovett E. 1982. Family studies in cancer of the colon and rectum. Br J Surg 63:13–18.Google Scholar
  117. 117.
    Lynch HT, Albano WA, Ruma TA, Schmitz GD, Costello KA, Lynch JF. 1983. Surveillance/management of an obligate gene carrier: the Cancer Family Syndrome. Gastroenterology 84:404–408.PubMedGoogle Scholar
  118. 118.
    Lynch HT, Harris RE, Organ CH, Guirgis HA, Lynch PM, Lynch JF, Nelson EJ. 1977. The surgeon, genetics, and cancer control: the Cancer Family Syndrome. Ann Surg 185: 435–440.PubMedGoogle Scholar
  119. 119.
    Lynch HT, Lynch P, Follett K, Harris RE. 1979. Familial polyposis coli: heterogeneous polyp expression in two kindreds. J Med Genet 16:1–7.PubMedGoogle Scholar
  120. 120.
    Bremond A, Collet P, Lambert R, Martin JL. 1984. Breast cancer and polyps of the colon: a case/control study. Cancer 54:2568–2570.PubMedGoogle Scholar
  121. 121.
    Miller LJ, Bartholomew LG, Dozois RR, Dahlin DC. 1983. Adenocarcinoma of the rectum arising in a hamartomatous polyp in a patient with Peutz-Jegher’s syndrome. Dig Dis Sci 28:1047.Google Scholar
  122. 122.
    Maskens AP. 1982. Adenomas and carcinomas of the large bowel: distinct diseases possibly sharing common etiologic factors? Acta Gastroenterol Belg XLV: 158.Google Scholar
  123. 123.
    Maskens AP, Dujardin-Loits RM. 1981. Experimental adenomas and carcinomas of the large intestine behave as distinct entities: most carcinomas arise de novo in flat mucosa. Cancer 47:81.PubMedGoogle Scholar
  124. 124.
    Pozharisski KM, Likhachev AJ, Klimashevski VI, Shaposhnikov JD. 1979. Experimental intestinal cancer research with special reference to human pathology. Adv Cancer Res 30:165.PubMedGoogle Scholar
  125. 125.
    Deschner EE. 1978. Early proliferative defects induced by six weekly injections of 1,2-dimethylhydrazine in epithelial cells of mouse distal colon. Z Krebsforsch 91:205.Google Scholar
  126. 126.
    Nair P, Turjman N. 1983. Role of bile acids and neutral sterols in familial cancer syndromes of the colon. Dis Colon Rect 26:629.Google Scholar
  127. 127.
    Lipkin M, Reddy BS, Weisburger J, Schechter L. 1981. Nondegradation of fecal cholesterol in subjects at high risk for cancer of the large intestine. J Clin Invest 67:304.PubMedGoogle Scholar
  128. 128.
    McKeown-Eyssen GE, Bright-See E. 1984. Dietary factors in colon cancer: international relationships. Nut Cancer 6(3): 160–170.Google Scholar
  129. 129.
    Lipkin M, Uehara K, Winawer S, Sanchez A, Bauer C, Phillips R, Lynch HT, Blattner WA, Fraumeni JF. 1985. Seventh-Day Adventist vegetarians have a quiescent proliferative activity in colonic mucosa. Ca Ltrs 26:139–144.Google Scholar
  130. 130.
    Rundgren A, Mellstrom D. 1983. Cholecystectomy and colon cancer in the elderly. Age Aging 12:44–49.Google Scholar
  131. 131.
    Timmen MJ, Kivilaakro EO. 1981. Increased risk of colorectal cancer after cholecystectomy. Ann Surg 194:639–641.Google Scholar
  132. 132.
    Nair PP. (ed). 1984. Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer. Am J Clin Nutr 40(Suppl): 879–963.Google Scholar
  133. 133.
    Hunter T. 1984. Oncogenes and proto-oncogenes: how do they differ? JNCI 73:773.PubMedGoogle Scholar
  134. 134.
    Murphree AL, Benedict WF. 1984. Retinoblastoma: clues to human oncogenesis. Science 223:1028.PubMedGoogle Scholar
  135. 135.
    Spandidos DA, Kerr IB. 1984. Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum. Br J Cancer 49:681.PubMedGoogle Scholar
  136. 136.
    Feig LA, Bast RC, Knapp RC, Cooper GM. 1984. Somatic activation of ras K gene in a human ovarian carcinoma. ICRDB 84(11):9.Google Scholar
  137. 137.
    Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Delia Porta G, Barbacid M. 1984. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. ICRDB 84(11):9.Google Scholar
  138. 138.
    Knudson AG. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820.PubMedGoogle Scholar
  139. 139.
    Cline MJ, Slamon DJ, Lipsick JS. 1984. Oncogenes: implications for the diagnosis and treatment of cancer. Ann Int Med 101:223.PubMedGoogle Scholar
  140. 140.
    Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RG, Skolnick MH. 1985. Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 312: 1540–1544.PubMedGoogle Scholar
  141. 141.
    Botstein D, White RL, Skolnick M, Davis RW. 1980. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32: 314–331.PubMedGoogle Scholar
  142. 142.
    Skolnick MH, Willard HF, Menlov LA. 1984. Report of the committee on human gene mapping by recombinant DNA techniques. Cytogenet Cell Genet 37:210–273.PubMedGoogle Scholar
  143. 143.
    Mulvihill JJ. 1985 Clinical ecogenetics: cancer in families. N Engl J Med 312: 1569–1570.PubMedGoogle Scholar
  144. 144.
    Lynch HT, Follett KL, Lynch PM, Albano WA, Mailliard, JL, Pierson RL. 1979. Family history in an oncology clinic: implications for cancer genetics. JAMA 242:1268–1272.PubMedGoogle Scholar
  145. 145.
    Mulvihill JJ. 1984. Clinical ecogenetics of human cancer. In: Genes and Cancer (JM Bishop, JD Rowley, M Greaves, eds.). Alan R. Liss, New York, pp 19–36.Google Scholar
  146. 146.
    Blattner WA. 1977. Family studies: the interdisciplinary approach. In: Genetics of Human Cancer (JJ Mulvihill, RW Miller, JF Fraumeni, eds.). Raven Press, New York, pp 269–280.Google Scholar
  147. 147.
    Bussey HJR. 1975. Familial Polyposis Coli. Johns Hopkins Univ Press, Baltimore, pp 104.Google Scholar
  148. 148.
    Jarvinen HJ, Peltokallio P, Landtman M, Wolf J. 1982. Gardner’s stigmas in patients with familial adenomatosis coli. Br J Surg 69:718–721.PubMedGoogle Scholar
  149. 149.
    Sayed AK, Jafri SZH, Shenoy SS. 1979. Intestinal polyposis and brain tumor in a family. Dis Colon Rect 22:486–491.Google Scholar
  150. 150.
    Gardner EJ, Richards RC. 1953. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5: 139–147.PubMedGoogle Scholar
  151. 151.
    Berlinger NT, Good RA. 1980. Suppressor cells in healthy relatives of patients with hereditary colon cancer. Cancer 45:1112–1116.PubMedGoogle Scholar
  152. 152.
    Blaire NP, Trempe CL. 1980. Hypertrophy of the retinal pigment epithelium associated with Gardner’s syndrome. Am J Opth 90:661–667.Google Scholar
  153. 153.
    Turcot J, Despres JP, St. Pierre F. 1959. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rect 2:465–468.Google Scholar
  154. 154.
    Baughman FA, List CF, Williams JR, Muldoon JP, Segarra JM, Volkel JS. 1969. The glioma-polyposis syndrome. N Engl J Med 281:1345–1346.PubMedGoogle Scholar
  155. 155.
    Lynch HT, Fusaro RM. 1982. Cancer-Associated Genodermatoses. Van Nostrand Reinhold Company, New York.Google Scholar
  156. 156.
    Lewis JH, Ginsberg AL, Toomey KE. 1983. Turcot’s syndrome: evidence for autosomal dominant inheritance. Cancer 51:524–528.PubMedGoogle Scholar
  157. 157.
    Lynch HT, Fusaro RM. 1982. Genodermatoses and cancer. In: Cancer-Associated Genodermatoses (HT Lynch, RM Fusaro, eds.). Van Nostrand Reinhold Co., New York, PP 9.Google Scholar
  158. 158.
    Oldfield MC. 1954. The association of familial polyposis of the colon with multiple sebaceous cysts. Br J Surg 41:534–541.PubMedGoogle Scholar
  159. 159.
    Nuss DD, Aeling JL, Clemons DE, Weber WN. 1978. Multiple hamartoma syndrome (Cowden’s disease). Arch Derm 114:743–746.PubMedGoogle Scholar
  160. 160.
    Lynch HT, Lynch PM. 1978. Heredity and gastrointestinal tract cancer. In: Gastrointestinal Tract Cancer (M. Lipkin, RA Good, eds.). Plenum, New York, pp 241–274.Google Scholar
  161. 161.
    Lynch HT, Danes BS, Lipkin M, Deschner E, Albano W, Kimberling W, Sandberg A, Lynch J, Costello K, Mikol Y, Schuelke G, Elston R, Bailey-Wilson J. 1983 Biomarkers and the Cancer Family Syndrome (CFS). Proc ASCO, Abstract C-21, 22–24 May 1983.Google Scholar
  162. 162.
    Guirgis HA, Lynch HT, Harris RE, Vandevoorde JP. 1978. Genetic and communicable effects on carcinoembryonic antigen expressivity in the Cancer Family Syndrome. Cancer Res 38:2523–2528.PubMedGoogle Scholar
  163. 163.
    Sivak MV, Sivak DS, Braun WA, Sullivan BH. 1981. A linkage study of HLA and inherited adenocarcinoma of the colon. Cancer 48:76–81.PubMedGoogle Scholar
  164. 164.
    Lynch HT, Thomas RJ, Terasaki PI, Ting A, Guirgis HA, Kaplan AR, Magee H, Lynch J, Kraft C, Chaperon E. 1975. HLA in cancer family ‘N’. Cancer 36:1315–1320.PubMedGoogle Scholar
  165. 165.
    Kopelovich L, Bias N. 1980. Tumor promoter induces loss of anchorage dependence in human skin fibroblasts from individuals genetically predisposed to cancer. Exp Cell Biol 48:207–217.PubMedGoogle Scholar
  166. 166.
    Schuelke GS, Lynch HT, Chaperon EA. 1985. Immunological parameters as possible biomarkers for disclosure of cancer-prone genotypes in familial cancer. In: Colon Cancer Genetics (PM Lynch, HT Lynch, eds.). Van Nostrand Reinhold Co., New York.Google Scholar
  167. 167.
    Herlyn M, Sears HF, Steplewski Z, Koprowski H. 1982. Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol. 2:135–140.PubMedGoogle Scholar
  168. 168.
    Bloom D, German J. 1971. The syndrome of congenital telangiectatic erythema and stunted growth. Arch Derm 103:545–546.PubMedGoogle Scholar
  169. 169.
    Fusaro RM, Lynch HT. 1982. Cutaneous signs of cancer-associated genodermatoses. In: Cancer-Associated Genodermatoses (HT Lynch, RM Fusaro, eds.). Van Nostrand Reinhold Co., New York, pp 105.Google Scholar
  170. 170.
    Collins DC. 1959. The frequent association of other body tumors with familial polyposis. Am J Gastroenterol 31:376–381.PubMedGoogle Scholar
  171. 171.
    Leppard B, Bussey HJ. 1976. Epidermoid cysts, polyposis coli, and Gardner’s syndrome. Br J Surg 62:387.Google Scholar
  172. 172.
    Halsted J A, Harris EJ, Bartlett MK. 1950. Involvement of the stomach in familial polyposis of the gastrointestinal tract: report of a family. Gastroenterology 15:763.PubMedGoogle Scholar
  173. 173.
    Hoffman DC, Goligher JC. 1971. Polyposis of the stomach and small intestine in association with familial polyposis coli. Br J Surg 58:126.Google Scholar
  174. 174.
    Ushio K, Ichikawa H, Yamada T, Sasagawa M. 1977. Gastric and duodenal lesions associated with familial polyposis coli. Stomach Intestine 12:1547–1557.Google Scholar
  175. 175.
    Murphy ES, Mireles M, Beltron A. 1962. Familial polyposis of the colon and gastric carcinoma. JAMA 179:1026.PubMedGoogle Scholar
  176. 176.
    Ranzi T, Castagnone D, Velio P, Blanchi P, Polli E. 1981. Gastric and duodenal polyps in familial polyposis coli. Gut 22:363.PubMedGoogle Scholar
  177. 177.
    Jones JR, Nance FL. 1977. Periampullary malignancy in Gardner’s syndrome. Ann Surg 185:565.PubMedGoogle Scholar
  178. 178.
    Maonald JM, David WC, Crago HR, Berk AD. 1967. Gardner’s syndrome and periampullary malignancy. Am J Surg 113:425.Google Scholar
  179. 179.
    Mdam WAF, Goligher JC. 1970. The occurrence of desmoids in patients with familial polyposis coli. Br J Surg 57:618.Google Scholar
  180. 180.
    Crail HW. 1949. Multiple primary malignancies arising in rectum, brain, and thyroid: report of a case. US Nav Med Bull 49:123.Google Scholar
  181. 181.
    Camiel MR, Mule JE, Alexander LL, Benninghoff DL. 1968. Association of thyroid carcinoma with Gardner’s syndrome in siblings. N Engl J Med 279:326.PubMedGoogle Scholar
  182. 182.
    Dowton SB. 1980. Familial polyposis coli associated with familial meningiomas. Med J Aust 1:615.PubMedGoogle Scholar
  183. 183.
    Parks TG, Bussey HJR, Lockhart-Mummery HE. 1970. Familial polyposis associated with extracolonic abnormalities. Gut 11:323–329.PubMedGoogle Scholar
  184. 184.
    Naylor EW, Gardner EJ. 1981. Adrenal adenomas in a patient with Gardner’s syndrome. Clin Genet 20:67–73.PubMedGoogle Scholar
  185. 185.
    Devec A, Bussy MM. 1912. Un cas de polypose adenomateuse: Genesalisee a tout l’intestin. Arch Mai Appar Dig 6:278–289.Google Scholar
  186. 186.
    Marshall WH, Martin FIR, Maay IR. 1967. Gardner’s syndrome with adrenal carcinoma. Aust Ann Med 16:242–244.PubMedGoogle Scholar
  187. 187.
    Lees CD, Hermann RE. 1981. Familial polyposis coli associated with bile duct cancer. Am J Surg 141:378–380.PubMedGoogle Scholar
  188. 188.
    Coli RD, Moore JP, Larche PH, Duca FG, Thayer WR. 1970. Gardner’s syndrome: a revisit to a previously described family. Dig Dis 15:551.Google Scholar
  189. 189.
    Weston SD, Wiener M. 1967. Familial polyposis associated with a new soft tissue lesion (skin pigmentation). Dis Colon Rect 10:311Google Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1987

Authors and Affiliations

  • Henry T. Lynch
  • Stephen J. Lanspa
  • Jane F. Lynch

There are no affiliations available

Personalised recommendations